Cuba
Tuberculosis profile
Population  2013 11 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.037 (0.037–0.037) 0.33 (0.32–0.33)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.03–0.06)
Prevalence  (includes HIV+TB) 1.5 (0.71–2.5) 13 (6.3–22)
Incidence  (includes HIV+TB) 1 (0.92–1.2) 9.3 (8.2–11)
Incidence (HIV+TB only) 0.026 (0.023–0.03) 0.23 (0.2–0.26)
Case detection, all forms (%) 72 (62–82)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.74 (0.09–2.7) 3.4 (0.41–12)
MDR-TB cases among notified pulmonary
TB cases
5 (1–17) 3 (0–9)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 484   52
Pulmonary, clinically diagnosed 142   5
Extrapulmonary 73   1
       
Total new and relapse 757    
Previously treated, excluding relapses 18    
Total cases notified 775    
Among 757 new and relapse cases:
9 (1%) cases aged under 15 years; male:female ratio: 3.1
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 274 (57%) 60 (79%) 339
Laboratory-confirmed RR-/MDR-TB cases     9
Patients started on MDR-TB treatment     3
TB/HIV 2013 Number (%)
TB patients with known HIV status 710 (92)
HIV-positive TB patients 61 (9)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 13 (21)
HIV-positive TB patients on antiretroviral therapy (ART) 43 (70)
HIV-positive people screened for TB 1 603  
HIV-positive people provided with IPT 1 438  
Treatment success rate (%)
New and relapse cases registered in 2012 85
Previously treated cases, excluding relapse, registered in 2012 30
HIV-positive TB cases, all types, registered in 2012 54
RR-/MDR-TB cases started on second-line treatment in 2011 75
XDR-TB cases started on second-line treatment in 2011 0
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 27
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-08-30 Data: www.who.int/tb/data